489 related articles for article (PubMed ID: 18222569)
1. CNS depressant and anticonvulsant activities of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones.
Jatav V; Mishra P; Kashaw S; Stables JP
Eur J Med Chem; 2008 Sep; 43(9):1945-54. PubMed ID: 18222569
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and CNS depressant activity of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones.
Jatav V; Mishra P; Kashaw S; Stables JP
Eur J Med Chem; 2008 Jan; 43(1):135-41. PubMed ID: 17418452
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, anticonvulsant and CNS depressant activity of some new bioactive 1-(4-substituted-phenyl)-3-(4-oxo-2-phenyl/ethyl-4H-quinazolin-3-yl)-urea.
Kashaw SK; Kashaw V; Mishra P; Jain NK; Stables JP
Eur J Med Chem; 2009 Nov; 44(11):4335-43. PubMed ID: 19674817
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anticonvulsant activity of some substituted 1,2,4-thiadiazoles.
Gupta A; Mishra P; Pandeya SN; Kashaw SK; Kashaw V; Stables JP
Eur J Med Chem; 2009 Mar; 44(3):1100-5. PubMed ID: 18672318
[TBL] [Abstract][Full Text] [Related]
5. N'-[(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)methylene] 2/4-substituted hydrazides: synthesis and anticonvulsant activity.
Kaushik D; Khan SA; Chawla G; Kumar S
Eur J Med Chem; 2010 Sep; 45(9):3943-9. PubMed ID: 20573423
[TBL] [Abstract][Full Text] [Related]
6. Design & synthesis of 2-(substituted aryloxy)-5-(substituted benzylidene)-3-phenyl-2,5-dihydro-1H-[1,2,4] triazin-6-one as potential anticonvulsant agents.
Kaushik D; Khan SA; Chawla G
Eur J Med Chem; 2010 Sep; 45(9):3960-9. PubMed ID: 20573424
[TBL] [Abstract][Full Text] [Related]
7. 3-Chloro-2-methylphenyl-substituted semicarbazones: synthesis and anticonvulsant activity.
Yogeeswari P; Thirumurugan R; Kavya R; Samuel JS; Stables J; Sriram D
Eur J Med Chem; 2004 Aug; 39(8):729-34. PubMed ID: 15276306
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization, and biological-pharmacological evaluation of new phosphazenes bearing dioxybiphenyl and schiff base groups.
Cil E; Tanyildizi MA; Ozen F; Boybay M; Arslan M; Gorgulu AO
Arch Pharm (Weinheim); 2012 Jun; 345(6):476-85. PubMed ID: 22415712
[TBL] [Abstract][Full Text] [Related]
9. Anticonvulsant and neurotoxicity evaluation of some 6-substituted benzothiazolyl-2-thiosemicarbazones.
Yogeeswari P; Sriram D; Mehta S; Nigam D; Kumar MM; Murugesan S; Stables JP
Farmaco; 2005 Jan; 60(1):1-5. PubMed ID: 15652361
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anticonvulsant activity of some novel 3-aryl amino/amino-4-aryl-5-imino-Delta2-1,2,4-thiadiazoline.
Gupta A; Mishra P; Kashaw SK; Jatav V; Stables JP
Eur J Med Chem; 2008 Apr; 43(4):749-54. PubMed ID: 17624632
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anticonvulsant activity of some 2-(2-{1-[substituted phenyl]ethylidene}hydrazinyl)-4-(4-methoxy-phenyl)-6-oxo-1,6-dihydro-pyrimidine-5-carbonitrile.
Shaquiquzzaman M; Khan SA; Amir M; Alam MM
J Enzyme Inhib Med Chem; 2012 Dec; 27(6):825-31. PubMed ID: 21981001
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and screening of quinoline-incorporated thiadiazole as a potential anticonvulsant.
Kumar S; Kaushik D; Bawa S; Khan SA
Chem Biol Drug Des; 2012 Jan; 79(1):104-11. PubMed ID: 21985632
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, Molecular Docking and Evaluation of 3-{4-[2-amino-4-(substitutedphenyl)-2H-[1, 3] oxazin/thiazin-6-yl} 2-phenyl-3H-quinazolin-4-one Derivatives for their Anticonvulsant Activity.
Jain N; Jaiswal J; Pathak A; Singour PK
Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):63-73. PubMed ID: 28056730
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of some quinoline-2(1H)-one and 1, 2, 4 - triazolo [ 4 , 3 -a ] quinoline derivatives as potent anticonvulsants.
Guan LP; Jin QH; Tian GR; Chai KY; Quan ZS
J Pharm Pharm Sci; 2007; 10(3):254-62. PubMed ID: 17727789
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Anticonvulsant Activity Evaluation of 4-Phenyl-[1,2,4]triazolo[4,3-a]quinazolin-5(4H)-one and Its Derivatives.
Zhang HJ; Jin P; Wang SB; Li FN; Guan LP; Quan ZS
Arch Pharm (Weinheim); 2015 Aug; 348(8):564-74. PubMed ID: 26053879
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anticonvulsant activity of acetylenic quinazolinone derivatives.
Usifoh CO; Scriba GK
Arch Pharm (Weinheim); 2000 Aug; 333(8):261-6. PubMed ID: 11008376
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of aryl semicarbazones as potential anticonvulsant agents.
Yogeeswari P; Sriram D; Veena V; Kavya R; Rakhra K; Ragavendran JV; Mehta S; Thirumurugan R; Stables JP
Biomed Pharmacother; 2005; 59(1-2):51-5. PubMed ID: 15740936
[TBL] [Abstract][Full Text] [Related]
18. Search for possible CNS depressant compounds: Part II. Synthesis of some new 1-(2'-methoxy-4'-nitrophenyl)-2-phenyl-4-substituted arylidene-5-imidazolones as CNS depressants.
Mukerji DD; Nautiyal SR; Prasad CR
Pol J Pharmacol Pharm; 1981; 33(6):633-7. PubMed ID: 7347813
[TBL] [Abstract][Full Text] [Related]
19. Benzothiazole incorporated barbituric acid derivatives: synthesis and anticonvulsant screening.
Siddiqui N; Ahsan W
Arch Pharm (Weinheim); 2009 Aug; 342(8):462-8. PubMed ID: 19565603
[TBL] [Abstract][Full Text] [Related]
20. Anticonvulsant and neurotoxicity evaluation of some novel kojic acids and allomaltol derivatives.
Aytemir MD; Calis U
Arch Pharm (Weinheim); 2010 Mar; 343(3):173-81. PubMed ID: 20108269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
